VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 33 filers reported holding VASCULAR BIOGENICS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 798 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 798 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 798 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 798 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 798 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 798 | +2651.7% | 0.00% | – |
| Q4 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 29 | +123.1% | 0.00% | – |
| Q1 2018 | $0 | – | 13 | -7.1% | 0.00% | – |
| Q4 2017 | $0 | – | 14 | +40.0% | 0.00% | – |
| Q1 2017 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 1,401,778 | $1,360,000 | 3.03% |
| SABBY MANAGEMENT, LLC | 2,373,203 | $2,302,000 | 0.51% |
| RBF Capital, LLC | 363,724 | $353,000 | 0.05% |
| Anson Funds Management LP | 45,998 | $45,000 | 0.03% |
| A.R.T. Advisors, LLC | 19,778 | $19,000 | 0.00% |
| Alyeska Investment Group, L.P. | 83,333 | $81,000 | 0.00% |
| Spark Investment Management LLC | 14,200 | $13,000 | 0.00% |
| J.P. Morgan Private Wealth Advisors LLC | 135,000 | $131,000 | 0.00% |
| Burt Wealth Advisors | 1,674 | $2,000 | 0.00% |
| Citadel Advisors | 15,776 | $15,000 | 0.00% |